Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
294.60    -3.60 (-1.21%)
Bid:
292.80
Ask:
293.40
Spread: 0.60 (0.205%)
Market Cap: £1.02b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

1 Oct 2013 15:58

RNS Number : 4596P
Breedon Aggregates Ld
01 October 2013
 



 

 

1 October 2013

BREEDON AGGREGATES LIMITED

("Breedon" or the "Company")

 

Directors' Dealings

 

Further to the Company's announcement on 9 September 2013, Breedon now announces that, on 1 October 2013, pursuant to the exercise of put options granted under the Management Participation Shares arrangement, the directors whose names are set out below were each allotted the number of ordinary shares of nil par value in the Company ("Ordinary Shares") set against their name in the table below.

 

The Company further announces that, following the allotment referred to above, each director sold the number of Ordinary Shares set against their name in the third column below for 31.0p per share and, as a consequence, each director now has an interest in the number of Ordinary Shares set against their name in the fourth column below.

 

 

 

 

 

Director's name

 

 

 

Ordinary Shares Allotted

 

 

 

Ordinary Shares Sold

 

 

 

Retained Interest in Ordinary Shares

Percentage of Total Voting Rights following the transaction

Peter Tom CBE

18,649,926

6,700,000

47,741,867

4.74%

Simon Vivian

18,649,926

5,000,000

16,519,647

1.64%

Ian Peters

9,324,963

5,000,000

6,337,348

0.63%

 

 

Following the above allotment, and the allotment of 12,346,584 new Ordinary Shares issued pursuant to the exercise of the Marwyn Participation Shares announced on 24 September 2013, there will be 1,006,720,790 Ordinary Shares in issue. This number may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

 

Enquiries:

Breedon Aggregates Limited

 

Simon Vivian, Group Chief Executive

01332 694010

 

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities plc (NOMAD)

Max Hartley

020 7397 8900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFESIRLLIIV
Date   Source Headline
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company
22nd May 202311:24 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
19th May 20237:00 amRNSHolding(s) in Company
18th May 20234:52 pmRNSDirector/PDMR Shareholding
18th May 20239:00 amRNSBreedon plays key role in Peak Cluster initiative
18th May 20238:00 amRNSAcquisitions
17th May 20238:00 amRNSReadmission - Breedon Group plc
17th May 20237:00 amRNSAdmission to Main Market
12th May 20236:00 pmRNSBreedon Group
12th May 20233:50 pmRNSDirector/PDMR Shareholding
11th May 202312:56 pmRNSPublication of Prospectus
4th May 202310:06 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20234:41 pmRNSResult of Scheme Meetings & Annual General Meeting
26th Apr 20237:00 amRNSAGM Trading Update
24th Apr 20232:22 pmRNSHolding(s) in Company
13th Apr 20236:08 pmRNSHolding(s) in Company
13th Apr 202312:12 pmRNSHolding(s) in Company
12th Apr 20234:50 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSPublication of Scheme Document
24th Mar 20233:49 pmRNSHolding(s) in Company
20th Mar 20239:00 amRNS2022 Annual Report and Notice of AGM
10th Mar 20235:34 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSResults of Reverse Accelerated Bookbuild
9th Mar 20234:56 pmRNSStatement re Reverse Accelerated Bookbuild
9th Mar 20231:36 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSIntention to move from AIM to the Main Market
8th Mar 20237:00 amRNSFinal Results
8th Feb 20238:00 amRNSNotice of Results
6th Feb 20231:29 pmRNSDirector/PDMR Shareholding
6th Jan 202310:08 amRNSBlocklisting Update
23rd Dec 202210:00 amRNSTotal Voting Rights
19th Dec 202212:57 pmRNSHolding(s) in Company
2nd Dec 20224:01 pmRNSHolding(s) in Company
30th Nov 20229:28 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSNovember trading statement
27th Oct 20224:23 pmRNSStandard form for notification of major holdings
26th Oct 20229:18 amRNSNotice of trading update
3rd Oct 20223:27 pmRNSPDMR Dealings
30th Sep 20224:20 pmRNSDirector Dealings
23rd Sep 20225:09 pmRNSStandard form for notification of major holdings
6th Sep 20225:19 pmRNSStandard form for notification of major holdings
25th Aug 20224:13 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSInterim results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.